Study type

Study topic

Human medicinal product

Study type

Non-interventional study

Scope of the study

Drug utilisation

Data collection methods

Secondary use of data
Study drug and medical condition

Study drug International non-proprietary name (INN) or common name

TELMISARTAN
AMLODIPINE
HYDROCHLOROTHIAZIDE

Anatomical Therapeutic Chemical (ATC) code

(C09CA07) telmisartan
telmisartan
(C08CA01) amlodipine
amlodipine
(C03AA03) hydrochlorothiazide
hydrochlorothiazide

Medical condition to be studied

Hypertension
Population studied

Age groups

  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)

Estimated number of subjects

3275
Study design details

Study design

retrospective, observational study

Main study objective

The primary objective of this study is to compare the medication adherence measured by PDC (Proportion of Days Covered) of patients with FDC (fixed dose combination) or double-pill combination therapy in real-world Japanese therapeutic practice.

Setting

Japanese prescription database

Outcomes

PDC of patients treated with single- and double- combination therapy, Demographic and clinical characteristics of patients treated with single- and double- combination therapy

Data analysis plan

Caliculate and compare the medication adherence (PDC) of patients with FDC or double-pill combination therapy in the following groups:
1)
• Telmisartan+ hydrochlorothiazide double-pill combination
• Telmisartan/hydrochlorothiazide single-pill combination (Micombi®)
2)
• Telmisartan+amlodipine double-pill combination
• Telmisartan/amlodipine single-pill combination (Micamlo®) Data are shown as the mean ±SD. Variables were compared by using Student’s t-test, or χ2 test, as appropriate. A p value less than 0.05 was accepted as indicative of statistical significance.To compare adjusted differences among single- and double-pill cohorts with respect to medication adherence (PDC≧80%), logistic regression model was applied.